P Llaneza
Overview
Explore the profile of P Llaneza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baquedano L, Coronado P, De la Viuda E, Sanchez S, Otero B, Ramirez I, et al.
Climacteric
. 2022 Nov;
26(1):47-54.
PMID: 36351874
Objective: This article aimed to study the use of menopausal hormone therapy (MHT) among Spanish perimenopausal and postmenopausal women, the presence of menopausal symptoms and the sources of information. Methods:...
2.
Cornellana M, Harvey X, Carballo A, Khartchenko E, Llaneza P, Palacios S, et al.
Climacteric
. 2017 Feb;
20(2):164-170.
PMID: 28140692
Objective: One of the most common complaints among postmenopausal women is a change in sexual drive. The aim of this study was to assess the current state of sexual health...
3.
Palacios S, Cancelo M, Castelo Branco C, Llaneza P, Molero F, Borrego R
Climacteric
. 2017 Jan;
20(1):55-61.
PMID: 28042734
Objectives: To gain a deeper comprehension of current vulvovaginal atrophy (VVA) knowledge among Spanish postmenopausal women. Methods: An online survey (REVIVE) was conducted in four European countries with an overall...
4.
Mendoza N, Hernandez C, Cornellana M, Carballo A, Llaneza P, Harvey X, et al.
Climacteric
. 2016 May;
19(4):375-80.
PMID: 27174039
Objective: To identify women's sociodemographic and variables related to health care with the prescription of hormonal therapy (HT) and phytotherapy (PT) in Spanish postmenopausal women. Method: The survey consisted of...
5.
Sanchez-Borrego R, Mendoza N, Llaneza P
Climacteric
. 2015 Oct;
18(6):813-6.
PMID: 26455645
Background: DT56a (Femarelle®) is a natural medication that contains a variety of phytoestrogens derived from tofu. Treatment with DT56a affects bones, vascular tissues and the nervous system in a manner...
6.
Sanchez-Borrego R, Navarro M, Llaneza P, Hormigo A, Duran M, Mendoza N
Climacteric
. 2014 Sep;
18(3):350-7.
PMID: 25236805
In this review, we analyze the efficacy and safety of DT56a in the treatment of postmenopausal symptoms. Similar to all selective estrogen receptor modulators (SERMs), DT56a demonstrates dual agonistic and...
7.
Soy isoflavones improve insulin sensitivity without changing serum leptin among postmenopausal women
Llaneza P, Gonzalez C, Fernandez-Inarrea J, Alonso A, Diaz F, Perez-Lopez F
Climacteric
. 2011 Dec;
15(6):611-20.
PMID: 22191384
Objective: To investigate the effect of a soy isoflavone extract over insulin sensitivity and plasma leptin levels. Methods: Eighty postmenopausal women were randomly assigned to participate for 24 months either...
8.
Ordonez P, Moreno M, Alonso A, Llaneza P, Diaz F, Gonzalez C
J Steroid Biochem Mol Biol
. 2008 Jul;
111(3-5):287-94.
PMID: 18657616
Recent clinical and experimental evidences suggest that sex steroids protect from insulin resistance associated with diabetes. Therefore, we have assessed the influence of E2 and/or P4 on insulin sensitivity by...
9.
Albert A, Altabre C, Baro F, Buendia E, Cabero A, Cancelo M, et al.
Phytomedicine
. 2002 May;
9(2):85-92.
PMID: 11995954
A multicentric, open, prospective, observational and no-randomized clinical trial was carried out in Spain with 190 postmenopausal women receiving a soy preparation rich in isoflavones (PHYTO SOYA, capsules containing 17.5...
10.
Ferrer J, Orille V, Llaneza P, Perez-Rodrigo C
Eur J Gynaecol Oncol
. 1995 Jan;
16(5):396-402.
PMID: 8549607
The malignant degeneration of a cystic teratoma of the ovary is a rare complication which different authors place at between 0.8 to 4%. Adenocarcinomas represent a relatively rare complication, 8%...